Efficacy and Safety of Inclisiran as Monotherapy in Chinese Adults With Low or Moderate ASCVD Risk and Elevated Low-density Lipoprotein Cholesterol.
Clinical trial NCT05888103 · COMPLETED
Trial details
- NCT number
- NCT05888103
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-11
- Primary completion
- 2024-04-02
- Enrollment
- 207
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.